These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
645 related items for PubMed ID: 6891268
21. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol. Stoff DM, Jeste DV, Gillin JC, Moja EA, Cohen L, Stauderman KA, Wyatt RJ. Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440 [No Abstract] [Full Text] [Related]
22. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions. Ossowska K, Wolfarth S. Pol J Pharmacol; 1995 Jan; 47(2):99-107. PubMed ID: 8688897 [Abstract] [Full Text] [Related]
23. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity? Surmann A, Havemann-Reinecke U. J Neural Transm Suppl; 1995 Jan; 45():143-55. PubMed ID: 8748620 [Abstract] [Full Text] [Related]
24. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL. Life Sci; 1988 Jan; 42(22):2207-15. PubMed ID: 3374255 [Abstract] [Full Text] [Related]
25. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat. Lai H, Carino MA, Horita A. Psychopharmacology (Berl); 1981 Jan; 75(4):388-90. PubMed ID: 6122233 [Abstract] [Full Text] [Related]
26. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol. Montanaro N, Dall'Olio R, Gandolfi O, Vaccheri A. Eur J Pharmacol; 1982 Jun 16; 81(1):1-9. PubMed ID: 6889533 [Abstract] [Full Text] [Related]
27. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine. Nakamura S, Engel J, Goldstein M. Commun Psychopharmacol; 1978 Jun 16; 2(3):185-90. PubMed ID: 29742 [No Abstract] [Full Text] [Related]
28. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats]. Zharkovskiĭ AM, Allikmets LKh, Nurk AM. Farmakol Toksikol; 1982 Jun 16; 45(1):10-2. PubMed ID: 7198997 [Abstract] [Full Text] [Related]
29. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats. Turrone P, Remington G, Kapur S, Nobrega JN. Psychopharmacology (Berl); 2003 Jan 16; 165(2):166-71. PubMed ID: 12417967 [Abstract] [Full Text] [Related]
34. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Rogoza RM, Fairfax DF, Henry P, N-Marandi S, Khan RF, Gupta SK, Mishra RK. Synapse; 2004 Dec 01; 54(3):156-63. PubMed ID: 15452862 [Abstract] [Full Text] [Related]
35. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity. Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS. Neuropeptides; 2005 Oct 01; 39(5):515-23. PubMed ID: 16154634 [Abstract] [Full Text] [Related]
37. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Neisewander JL, Lucki I, McGonigle P. Synapse; 1994 Jan 01; 16(1):1-10. PubMed ID: 8134896 [Abstract] [Full Text] [Related]
39. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)]. Sayers AC, Bürki HR. Arzneimittelforschung; 1976 Jan 01; 26(6):1092-3. PubMed ID: 989384 [Abstract] [Full Text] [Related]
40. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues. Waddington JL, Gamble SJ. Psychopharmacology (Berl); 1980 Jan 01; 71(1):75-7. PubMed ID: 6779327 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]